HIV-1 gp160 (315-329)

a highly immunogenic peptide from the V3 loop of the HIV-1 gp160 envelope protein; amino acid sequence given in first source

Also Known As:

P18(IIIB); P18III(B); P18IIIB

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 09/16/1996 - "We also show that the ability of cytotoxic T-lymphocytes (CTL) to lyse tumor cells presenting P18IIIB was completely abrogated by threonine glycosylation."
2.	Infections 01/01/2004 - "Here we show that vaginal infection of progesterone-treated BALB/c mice with a recombinant influenza virus bearing the immunodominant P18IIIB cytotoxic T-lymphocyte (CTL) epitope of the gp160 envelope protein from an HIV-1 IIIB isolate (P18IIIB; RIQRGPGRAFVTIGK) can induce a specific immune response in regional mucosal lymph nodes, as well as in a systemic site (the spleen). "